Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 3 (2006), Issue 11 (November)

1. Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro.
   Cancer Sci, 97(12): 1417-23. [Abstract] [Full-text]
2. Oncocytic non-functioning endocrine tumor of the pancreas.
   Pathol Int, 56(12): 755-9. [Abstract] [Full-text]
3. Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human insulinoma tumourigenesis.
   J Pathol, 210(4): 450-8. [Abstract] [Full-text]
4. Hedgehog/Ras interactions regulate early stages of pancreatic cancer.
   Genes Dev, 20(22): 3161-73. [Abstract] [Full-text]
5. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.
   Genes Dev, 20(22): 3147-60. [Abstract] [Full-text]
6. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.
   Genes Dev, 20(22): 3130-46. [Abstract] [Full-text]
7. Fine-needle aspiration biopsy of solid pancreatic masses: comparison of CT and endoscopic sonography guidance.
   AJR Am J Roentgenol, 187(6): 1531-5. [Abstract] [Full-text]
8. MDCT of pancreatic adenocarcinoma: optimal imaging phases and multiplanar reformatted imaging.
   AJR Am J Roentgenol, 187(6): 1513-20. [Abstract] [Full-text]
9. Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells.
   J Surg Res, 136(2): 325-35. [Abstract] [Full-text]
10. Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha.
    Cancer Chemother Pharmacol, 59(1): 113-26. [Abstract] [Full-text]
11. Middle segmental pancreatic resection: An option to treat benign pancreatic body lesions.
    Ann Surg, 244(6): 909-18; discussion 918-20. [Abstract] [Full-text]
12. An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors.
    Ann Surg, 244(6): 845-51; discussion 852-3. [Abstract] [Full-text]
13. The predictive value of CK19 and CD99 in pancreatic endocrine tumors.
    Am J Surg Pathol, 30(12): 1588-94. [Abstract] [Full-text]
14. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
    Am J Surg Pathol, 30(12): 1561-9. [Abstract] [Full-text]
15. Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation.
    Cancer, 107(11): 2589-96. [Abstract] [Full-text]
16. Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas.
    Cancer, 107(11): 2567-75. [Abstract] [Full-text]
17. Peutz-Jeghers syndrome and screening for pancreatic cancer.
    Br J Surg, 93(12): 1446-55. [Abstract] [Full-text]
18. Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer.
    Int J Radiat Oncol Biol Phys, 66(5): 1391-8. [Abstract] [Full-text]
19. Occupational risk factors for pancreatic cancer among female textile workers in Shanghai, China.
    Occup Environ Med, 63(12): 788-93. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.